Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Natural history and therapy of AL cardiac amyloidosis
Martha Grogan
,
Angela Dispenzieri
Cardiovascular Medicine
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
58
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Natural history and therapy of AL cardiac amyloidosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Amyloidosis
100%
Natural History
90%
Plasma Cells
25%
Survival
21%
Heart Failure
18%
Immunoglobulin Light-chain Amyloidosis
17%
pro-brain natriuretic peptide (1-76)
16%
Troponin
15%
Therapeutics
14%
Angiotensin Receptor Antagonists
14%
Sudden Cardiac Death
13%
Heart Transplantation
13%
Stem Cell Transplantation
13%
Mortality
12%
Diuretics
12%
Angiotensin-Converting Enzyme Inhibitors
12%
Cardiac Arrhythmias
10%
Early Diagnosis
10%
Clone Cells
10%
Hemodynamics
9%
Biomarkers
8%
Drug Therapy
7%